Gabelli Healthcare & Wellness Trust:GRX

    Manage Alerts


    As of 6/11/2021

    52 Wk Avg$11.56$13.53-14.66%
    52 Wk High$13.59$15.40-11.31%
    52 Wk Low$9.84$11.48-18.21%
    Regular Distribution TypeIncome Only
    Distribution Rate4.45%
    Distribution Amount$0.1500
    Distribution FrequencyQuarterly
    Past performance is no guarantee of future results.

    Basic Information

    Investment Objective

    The Healthcare Trust will invest at least 80% of its assets, plus borrowings made for investment purposes, in equity securities such as common stock and preferred stock and income producing securities, such as fixed income debt securities and securities convertible into common stock, of domestic and foreign companies in the healthcare and wellness industries. The remaining 20% of its assets may be invested in other securities, including stocks, debt obligations and money market instruments, as well as certain derivative instruments in the healthcare and wellness industries or other industries.

    Capital Structure

    As of 6/11/2021

    Total Investment Exposure:$310.024M
    Total Common Assets:$270.024M
    Common Shares Outstanding:17,534,031

    As of 6/11/2021

    Preferred Share Assets: $40.000M
    Total Debt (USD):
    Regulatory Leverage (USD): $40.000M
    Effective Leverage (USD): $40.000M
    Effective Leverage (%): 12.90%
    Annual Expense Ratios

    As of 12/31/2020

      Per Common Share
    Management FeesN/A
    Other Expenses:N/A
    Baseline Expense: N/A
    Interest Expense:N/A
    Total: 1.60%
    Fund Management

    Fund Sponsor

    Portfolio Managers
    Kevin V. Dreyer, Jeffrey J. Jonas, Jing He, Jennie Tsai, Sara Wojda, Mario J. Gabelli

    Category: Equity-Sector Equity
    Ticker: GRX
    NAV Ticker: XXGRX
    Average Daily Volume (shares): 44,191
    Average Daily Volume (USD): $0.501M
    Inception Date: 6/19/2007
    Inception Share Price: $8.00
    Inception NAV: $8.00
    Tender Offer: No
    Term: No
    Fiscal Year End: December 31
    Third Party Links & Reports


    As of 6/11/2021

    Past performance is no guarantee of future results.
    Distribution History

    Enter declared start and end dates to display distribution history below. Income, Long Gain, Short Gain and ROC breakdowns will only be shown for the past year.

    Declared Date Payable Date Ex Date Distrib Amount Income Long Gain Short Gain ROC

    *Indicates a Special Distribution: A distribution disbursed in addition to the normal distributions paid out by the company.

    Key Information Regarding Distributions
    Avg. Earnings Per Share:
    As of 12/31/2020
    Annualized Distribution Rate on NAV:
    As of 6/11/2021
    Total Return on NAV (12 months):
    As of 6/11/2021
    Total % Portfolio Effectively Leveraged:
    As of 6/11/2021

    Pricing Information

    Premium/Discount Information
    Past performance is no guarantee of future results.
    Premium/Discount Information

    As of 6/11/2021

    PeriodAvg Discount
    6 Month-13.28%
    1 Year-14.66%
    3 Year-14.16%
    5 Year-13.44%

    As of 6/11/2021

    3 Month0.64
    6 Month1.10
    1 Year1.34
    Pricing History
    Date NAV Premium / Discount


    Calendar Year Total Returns

    As of 5/31/2021
    Category: Morningstar US CEF Sector Equity

    Past 20 Years

    Return YearPriceNAVCategory - PriceCategory - NAV
    Past performance is no guarantee of future results.
    Annualized Total Returns

    Returns for periods less than one year are cumulative rather than annualized

    As of 5/31/2021
    Category: Morningstar US CEF Sector Equity

    Past performance is no guarantee of future results.

    Portfolio Characteristics

    Portfolio Characteristics
    Number of Holdings:
    As of 3/31/2021
    Annual Portfolio Turnover:
    As of 12/31/2020
    Asset Allocation

    As of 3/31/2021 reported by Fund Sponsor

    Top Sectors

    As of 3/31/2021 reported by Fund Sponsor

    Defensive (Super Sector)92.53%
    Consumer Defensive28.56%
    Cyclical (Super Sector)2.93%
    Cash Equivalents (Super Sector)2.31%
    Cash Equivalents2.31%
    Basic Materials2.18%
    Sensitive (Super Sector)1.47%
    Corporate (Super Sector)0.75%
    Top Holdings

    As of 3/31/2021 reported by Fund Sponsor

    HoldingValue% Portfolio
    Cigna Corp$8.99M3.12%
    HCA Healthcare Inc$8.48M2.95%
    CVS Health Corp$7.64M2.66%
    Nestle SA$7.47M2.59%
    Conagra Brands Inc$7.14M2.48%
    Johnson & Johnson$6.50M2.26%
    Anthem Inc$6.46M2.25%
    Thermo Fisher Scientific Inc$5.84M2.03%
    Merck & Co Inc$5.49M1.91%
    AmerisourceBergen Corp$5.31M1.85%
    Country Allocation

    As of 3/31/2021 reported by Fund Sponsor

    Country% Portfolio
    United States - Equity81.26%
    Japan - Equity5.16%
    Switzerland - Equity2.79%
    United Kingdom - Equity1.80%
    Canada - Equity1.70%
    Ireland - Equity1.53%
    France - Equity0.79%
    Germany - Equity0.77%
    Hong Kong - Equity0.57%
    Israel - Equity0.20%
    China - Equity0.20%
    Denmark - Equity0.08%
    Netherlands - Equity0.05%
    Belgium - Equity0.04%

    Closed-end fund historical distribution sources have included net investment income, realized gains, and return of capital. For more detailed information on the distributions of a specific fund, please visit the sponsor's website.


    Distribution type sourced from Morningstar. For specific information about a fund's distribution sources, visit the fund sponsor's website.

    The following information applies to closed-end funds in general: Fund shares are not guaranteed or endorsed by any bank or other insured depository institution, and are not federally insured by the Federal Deposit Insurance Corporation. Shares of closed-end funds are subject to investment risks, including the possible loss of principal invested. There can be no assurance that fund objectives will be achieved. Closed-end funds frequently trade at a discount to their net asset value. NAV returns are net of fund expenses, and assume reinvestment of distributions.